Educational Dose Illustrator for:
INVEGA SUSTENNA® (paliperidone palmitate)
INVEGA TRINZA® (paliperidone palmitate)
The Educational Dose Illustrator can be used to visualize how dosing affects paliperidone plasma concentrations following administration of:
INVEGA SUSTENNA® for:
- the treatment of schizophrenia in adults
- the treatment of schizoaffective disorder in adults as monotherapy and as an adjunct to mood stabilizers or antidepressants
INVEGA TRINZA® for:
- the treatment of schizophrenia in patients after they have been adequately treated with INVEGA SUSTENNA® for at least four months.
This resource simulates the paliperidone plasma concentrations over time resulting from different dosing scenarios that are set forth in the respective Prescribing Information for INVEGA SUSTENNA® and INVEGA TRINZA®. The Educational Dose Illustrator is intended to be used as a resource to foster a better understanding of, and educate healthcare professionals about, the dosing recommendations provided in the respective Prescribing Information for INVEGA SUSTENNA® and INVEGA TRINZA®. It is intended for educational purposes only.
Because the simulated patient paliperidone plasma levels shown in the dosing scenarios are based upon aggregated pharmacokinetic information from clinical studies, the simulations may not be representative of individual patient response.
Please Acknowledge
The information contained in this web site is intended for US healthcare professionals only. Privacy Policy.
View dosing information for
1MINVEGA SUSTENNA® (paliperidone palmitate) For Schizophrenia
1MINVEGA SUSTENNA® (paliperidone palmitate) For Schizoaffective Disorder
3MINVEGA TRINZA® (paliperidone palmitate) For Schizophrenia
© Janssen Scientific Affairs, LLC 2024. All rights reserved. cp-45525v5
This site is published by Janssen Scientific Affairs, LLC, which is solely responsible for its contents.
This information is intended for healthcare providers in the United States only.
Last updated 8/22/2023